VivoSim Labs, Inc. (VIVS)
VIVS Stock Price Chart
Explore VivoSim Labs, Inc. interactive price chart. Choose custom timeframes to analyze VIVS price movements and trends.
VIVS Company Profile
Discover essential business fundamentals and corporate details for VivoSim Labs, Inc. (VIVS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Feb 2012
Employees
14.00
Website
https://vivosim.aiCEO
Keith Murphy
Description
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
VIVS Financial Timeline
Browse a chronological timeline of VivoSim Labs, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
Earnings released on 14 Jul 2026
EPS came in at -$2.21 falling short of the estimated -$2.04 by -8.33%, while revenue for the quarter reached $40.00k , missing expectations by -25.93%.
Earnings released on 11 Feb 2026
EPS came in at -$1.03 surpassing the estimated -$2.40 by +57.08%, while revenue for the quarter reached $26.00k , missing expectations by -48.00%.
Earnings released on 6 Nov 2025
EPS came in at -$0.98 surpassing the estimated -$2.28 by +57.02%, while revenue for the quarter reached $28.00k , missing expectations by -44.00%.
Earnings released on 12 Aug 2025
EPS came in at -$1.14 , while revenue for the quarter reached $37.00k .
Earnings released on 30 May 2025
EPS came in at -$3.48 falling short of the estimated -$2.28 by -52.63%, while revenue for the quarter reached $51.00k .
Earnings released on 19 Feb 2025
EPS came in at -$0.19 surpassing the estimated -$2.52 by +92.46%, while revenue for the quarter reached $24.00k , missing expectations by -45.45%.
Earnings released on 8 Nov 2024
EPS came in at -$0.14 surpassing the estimated -$0.26 by +46.15%, while revenue for the quarter reached $30.00k .
Earnings released on 30 Jun 2024
EPS came in at -$2.74 , while revenue for the quarter reached $39.00k .
Earnings released on 31 Mar 2024
EPS came in at -$3.07 , while revenue for the quarter reached $29.00k .
Earnings released on 31 Dec 2023
EPS came in at -$4.74 , while revenue for the quarter reached $5.00k .
Earnings released on 30 Sept 2023
EPS came in at -$5.50 .
Earnings released on 30 Jun 2023
EPS came in at -$5.54 , while revenue for the quarter reached $75.00k .
Earnings released on 31 Mar 2023
EPS came in at -$10.27 , while revenue for the quarter reached $162.00k .
Earnings released on 31 Dec 2022
EPS came in at -$4.50 , while revenue for the quarter reached $131.00k .
Earnings released on 30 Sept 2022
EPS came in at -$4.57 , while revenue for the quarter reached $77.00k .
Earnings released on 30 Jun 2022
EPS came in at -$4.43 .
Earnings released on 31 Mar 2022
EPS came in at -$2.63 , while revenue for the quarter reached $1.50m .
Earnings released on 31 Dec 2021
EPS came in at -$4.82 .
Earnings released on 30 Sept 2021
EPS came in at -$4.83 .
VIVS Stock Performance
Access detailed VIVS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
